ERBB2 and breast carcinoma: Notably, gp78 is more expressed in the most aggressive forms of breast cancer, characterized by rapid growth and metastatic spread, including triple-negative breast cancer (TNBC), luminal B, and the human epidermal growth factor receptor 2 (HER2) overexpressed subtypes (Figure 1B, right).